The company will be utilising the newly acquired capital to propel the company’s growth across various crucial areas, such as acquisition of top talent, expanding retail presence, appointing key opinion leaders (KOLs), exploring new international markets, integrating cutting-edge technology to enhance treatment adherence, enhancing R&D efforts, and elevating customer retention efforts
Varco Leg Care, consumer health-tech company has announced raising a bridge funding round of Rs 2 crore to advance its mission of revolutionising leg care across India and the world. This round was led by Neeraj Garg, Former CEO, Hindustan Coca-Cola. Besides participation of existing investors, the round also witnessed participation from multiple new investors, including senior executives from Coca Cola, Emporia UAE, Highway Concessions One – a KKR company, and few HNIs.
The company will be utilising the newly acquired capital to propel the company’s growth across various crucial areas, such as acquisition of top talent, expanding retail presence, appointing key opinion leaders (KOLs), exploring new international markets, integrating cutting-edge technology to enhance treatment adherence, enhancing R&D efforts, and elevating customer retention efforts.
Speaking about the latest fundraise, Anondeep Ganguly, CEO, Varco Leg Care remarked, “We are happy to announce the successful conclusion of our bridge fundraise – which is a testament to the trust and confidence that our investors have in Varco Leg Care and our committed team. Additionally, the funding will play a major role in bolstering our mission of fostering a healthier, happier world, one leg at a time. Beyond pioneering effective leg care products with the help of advanced phyto and neural network technology, we at Varco are also empowering consumers to actively engage in diagnosing and managing their leg health. In the long run, we aim to become a global leader in the leg care solutions domain, and envision a world where all individuals move freely without any leg disorder burdens”.
Garg, who is the lead investor of the round, and has been recently appointed as an Individual Director of Nano Phyto Care, the parent company of Varco, expressed his confidence, saying, “This successful fundraise underscores the profound belief that investors have in Varco Leg Care. By creating breakthrough leg care solutions powered by phytotechnology and enabling consumers to proactively manage their well-being, Varco is ushering in an unforeseen positive transformation in the leg care space. Going forward, we foresee Varco Leg Care products becoming a household essential across our country and internationally too”.